medigraphic.com
Boletín Médico del Hospital Infantil de México

2008, Number 6

<< Back Next >>

Bol Med Hosp Infant Mex 2008; 65 (6)

Epidemiology and genetics of overweight and obesity. Mexico in the world context

López-Alarcón MG, Rodríguez-Cruz M

Language: Spanish
References: 41
Page: 421-430
PDF size: 156.59 Kb.


ABSTRACT

Obesity rates have drastically increased worldwide, particularly in women in reproductive-age as well as in children. This is relevant for the challenges that the health system will face in the near future. Recently, national surveys in Mexico and United States have shown a moderate decrease in the acceleration rates of obesity. Hopefully such behavior reflects results from preventive programs, or perhaps is due to methodological unidentified issues. Importantly, such decrease seems insufficient to reach the "ideal" prevalence of obesity. From the genetic point of view, based in the presence of the R230C polymorphism in the ABCA1 gene identified only in Amerindian populations it seems that some ethnic groups might be more susceptible to develop obesity. However, it is important to take into account that susceptibility may also be explained by interactions among variants in different genes. In conclusion, obesity prevalence in Mexico is close to those in developed countries, and it is particularly alarming in adolescents and women in reproductive-age. Evidence suggests that Mexican population might present a higher susceptibility, but more studies are needed.


REFERENCES

  1. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva: WHO; 1997.

  2. Sorensen TI. The changing lifestyle in the world. Body weight and what else? Diabetes Care. 2000; 23: B1-4.

  3. Ceschi M, Gutzwiller F, Moch H, Eichholzer M, Probst-Hensch NM. Epidemiology and pathophysiology of obesity as a cause of cancer. Swiss Med Wkly. 2007; 137: 50-6.

  4. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev. 2007; 29: 1-5.

  5. Popkin BM, Gordon-Larsen P. The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes Relat Metab Disord. 2004; 28: S2-9.

  6. Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet. 1997; 27: 325-51.

  7. Ogden CL, Carroli MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006; 295: 1549-55.

  8. INEGI Estadísticas de Mortalidad en México. Salud Publica Mex. 2005; 47: 171-87.

  9. Secretaría de Salud. Encuesta Nacional de Nutrición 1988; México: Dirección General de Epidemiología; 1988.

  10. Rivera-Dommarco J, Shama-Levy T, Villalpando-Hernández S, González-de Cosío T, Hernández-Prado BV, Sepúlveda J. Encuesta Nacional de Nutrición 1999. Estado nutricio de niños y mujeres en México. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública; 2001.

  11. Shama-Levy T, Villalpando-Hernández S, Rivera-Dommarco JA. Resultados de Nutrición de la ENSANUT 2006. Cuernavaca, México: Instituto Nacional de Salud Pública; 2007.

  12. World Health Organization. World Health Statistics 2008. WHO Library Cataloguing-in-Publication Data. France; 2008.

  13. World Health Organization Europe. The challenge of obesity in the WHO European region and the strategies for response. En: Branca F, Lobstein T, editores. Denmark: WHO; 2007.

  14. World Health Organization. Obesity: Preventing and managing the global epidemic. Geneva: World Health Organization; 2000.

  15. Ogden CL, Carroll MD, McDowell MA, Flegal KM. Obesity among adults in the United States- no statistically significant change since 2003-2004. NCHS Data Brief no 1. Hyattsville, MD: National Center for Health Statistics; 2007.

  16. Cnattingius S, Bergstrom R, Lipworth, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med. 1998; 338: 147-52.

  17. Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, et al. Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London. Int J Obes Relat Metab Disord. 2001; 25: 1175-82.

  18. Dempsey JC, Ashiny Z, Qiu CF, Miller RS, Sorensen TK, Williams MA. Maternal pre-pregnancy overweight status and obesity as risk factors for cesarean delivery. J Matern Fetal Neonatal Med. 2005; 17: 179-85.

  19. Deshmukh-Taskar P, Nicklas TA, Morales M, Yang SJ, Zakeri I, Berenson GS. Tracking of overweight status from childhood to young adulthood: the Bogalusa Heart Study. Eur J Clin Nutr. 2006; 60: 48-57.

  20. Ogden CL. Prevalence of overweight among children and adolescents: United States, 2003-2004. Consulted in May 27, 2008. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/overweight/overwght_child_03.htm

  21. Britos S, Clacheo R, Grippo B, O’Donell A, Pueyrredon P, Pujato D, et al. Obesidad en Argentina: Hacia un nuevo fenotipo? CESNI. 2004.

  22. Kain J, Uaui R, Vio F, Albala C. Trends in overweight and obesity prevalence in Chilean children: comparison of three definition. Eur J Clin Nutr. 2002; 56: 200-4.

  23. Amigo H. Obesidad en el niño en América Latina: situación, criterios de diagnóstico y desafíos. Cad Saude Publica. 2003; 19: S163-70.

  24. Bouchard C, Loos RJF. Obesity -is it a genetic disorder? J Intern Med. 2003; 254: 401-25.

  25. Bouchard C. Genetics of human obesity: recent results from linkage studies. J Nutr. 1997; 127: 1887S-90S.

  26. Barsh GS, Farooqi IS, O’Rahilly S. Genetics of bodyweight regulation. Nature. 2000; 404: 644-51.

  27. Comuzzie AG, Williams JT, Martin LJ, Blangero J. Searching for genes underlying normal variation in human adiposity. J Mol Med. 2001; 79: 57-70.

  28. O’Rahilly S, Farooqi IS, Yeo GS, Challis BG. Mini review: human obesity-lessons from monogenic disorders. Endocrinology. 2003; 144: 3757-64.

  29. Ochoa M, Marti A, Martínez J. Estudios sobre la obesidad en genes candidatos. Med Clin. 2004; 122: 542-51.

  30. Clement K, Boutin P, Froguel P. Genetics of obesity. Am J Pharmacogenomics. 2002; 2: 177-87.

  31. Roberts SB. The new obesity genes. Nutr Rev. 1996; 54: 41-9.

  32. Chen L, Velasco-Mondragón HE, Lazcano-Ponce E, Collins A, Shugart YY. Effect of the peroxisome proliferators-activated receptor (PPAR) gamma 3 gene on BMI in 1 210 school students from Morelos, Mexico. Pac Symp Biocomput. 2006; 11: 467-77.

  33. Villarreal-Molina MT, Aguilar-Salinas CA, Rodríguez-Cruz M, Riaño D, Villalobos-Comparan M, Coral-Vazquez R, et al. The ATP-binding cassette transporter A1 R230C variant affects HDL cholesterol levels and BMI in the Mexican population: association with obesity and obesity-related comorbidities. Diabetes. 2007; 56: 1881-7.

  34. Arya R, Duggirala R, Jenkinson CP, Almasy L, Blangero J, O’Connell P, et al. Evidence of a novel quantitative-trait locus for obesity on chromosome 4p in Mexican Americans. Am J Hum Genet. 2004; 74: 272-82.

  35. Dionne IJ, Turner AN, Tchernof A, Pollin TI, Avrithi D, Gray D, et al. Identification of an interactive effect of b3- and a2b- adrenoreceptor gene polymorphisms on fat mass in Caucasian women. Diabetes. 2001; 50: 91-5.

  36. Coleen M, Damcott CM, Sack P, Shuldiner AR. The genetics of obesity. Endocrinol Metab Clin North Am. 2003; 32: 761-86.

  37. Canizales-Quinteros CA, Aguilar-Salinas G, Ortiz-López M, Rodríguez-Cruz MT, Villarreal-Molina R, Coral-Vázquez A, et al. Association of PPARG2 Pro12Ala variant with larger body mass index in Mestizo and Amerindian populations of Mexico. Hum Biol. 2007; 79: 111-9.

  38. Consultado el 15 de junio 2008: http://obesitygene.pbrc.edu

  39. Need AC, Ahmadi KR, Spector TD, Goldstein DB. Obesity is associated with genetic variants that alter dopamine availability. Ann Hum Genet. 2006; 70: 293-303.

  40. EU Platform on Diet, Physical Activity and Health. International Obesity Task Force (IOTF). Brussels: EU Platform Briefing Paper; 2005.

  41. Consultado el 28 mayo 2008: http://www.who.int/infobase/report




2020     |     www.medigraphic.com